Assignee
SUGEN INC
US·158 granted patents·58 pending applications·8,206 citations·filing 1994–2010
Top patents by PatentIndex Score
216 records- 0199US5804396AAssay for agents active in proliferative disordersSUGEN INC·Filed 1994·Granted Sep 8, 1998·480 cites·18 claims
- 0298US6506763B23-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activitySUGEN INC·Filed 2001·Granted Jan 14, 2003·76 cites·22 claims
- 0398US6133305A3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activitySUGEN INC·Filed 1998·Granted Oct 17, 2000·125 cites·27 claims
- 0498US5886020A3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 23, 1999·376 cites·45 claims
- 0598US5883113A3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 16, 1999·373 cites·27 claims
- 0698US5834504A3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of diseaseSUGEN INC·Filed 1996·Granted Nov 10, 1998·358 cites·24 claims
- 0798US5792783A3-heteroaryl-2-indolinone compounds for the treatment of diseaseSUGEN INC·Filed 1996·Granted Aug 11, 1998·589 cites·28 claims
- 0898US5789427AMethods and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 1995·Granted Aug 4, 1998·264 cites·16 claims
- 0998US5773476AMethods and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 1995·Granted Jun 30, 1998·153 cites·17 claims
- 1097US6573293B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2001·Granted Jun 3, 2003·174 cites·29 claims
- 1197US6239161B1Method and compositions for inhibition of adaptor protein/tyrosine kinase interactionsSUGEN INC·Filed 2000·Granted May 29, 2001·54 cites·9 claims
- 1297US5883116A3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of diseaseSUGEN INC·Filed 1996·Granted Mar 16, 1999·180 cites·26 claims
- 1397US5773459AUrea- and thiourea-type compoundsSUGEN INC·Filed 1995·Granted Jun 30, 1998·117 cites·18 claims
- 1497US5763441ACompounds for the treatment of disorders related to vasculogenesis and/or angiogenesisSUGEN INC·Filed 1995·Granted Jun 9, 1998·111 cites·4 claims
- 1597US5650415AQuinoline compoundsSUGEN INC·Filed 1995·Granted Jul 22, 1997·235 cites·14 claims
- 1696US7125905B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2005·Granted Oct 24, 2006·59 cites·2 claims
- 1796US6683082B2Bicyclic protein kinase inhibitorsSUGEN INC·Filed 2001·Granted Jan 27, 2004·60 cites·34 claims
- 1896US5891917ACertain acrylonitrile-sulfonamide derivativesSUGEN INC·Filed 1997·Granted Apr 6, 1999·75 cites·16 claims
- 1995US6777417B23-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitorsSUGEN INC·Filed 2002·Granted Aug 17, 2004·56 cites·4 claims
- 2095US5990141ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1995·Granted Nov 23, 1999·189 cites·20 claims
- 2195US5935993ATyrphostin like compoundsSUGEN INC·Filed 1997·Granted Aug 10, 1999·72 cites·16 claims
- 2295US5880141ABenzylidene-Z-indoline compounds for the treatment of diseaseSUGEN INC·Filed 1995·Granted Mar 9, 1999·106 cites·7 claims
- 2395US5792771AQuinazoline compounds and compositions thereof for the treatment of diseaseSUGEN INC·Filed 1995·Granted Aug 11, 1998·155 cites·12 claims
- 2495US5763198AScreening assays for compoundsSUGEN INC·Filed 1994·Granted Jun 9, 1998·155 cites·22 claims
- 2594US7211600B2Methods of modulating c-kit tyrosine protein kinase function with indolinone compoundsSUGEN INC·Filed 2005·Granted May 1, 2007·49 cites·4 claims
- 2694US6653308B23-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitorsSUGEN INC·Filed 2002·Granted Nov 25, 2003·75 cites·40 claims
- 2794US6610688B24-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitorsSUGEN INC·Filed 2000·Granted Aug 26, 2003·74 cites·22 claims
- 2894US5700823ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1994·Granted Dec 23, 1997·122 cites·23 claims
- 2993US7572924B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2006·Granted Aug 11, 2009·25 cites·3 claims
- 3093US6841579B1Diagnosis and treatment of AUR1 and/or AUR2 related disordersSUGEN INC·Filed 2001·Granted Jan 11, 2005·125 cites·7 claims
- 3193US6677368B24-aryl substituted indolinonesSUGEN INC·Filed 2001·Granted Jan 13, 2004·72 cites·20 claims
- 3293US6326469B1Megakaryocytic protein tyrosine kinasesSUGEN INC·Filed 1995·Granted Dec 4, 2001·184 cites·11 claims
- 3393US6316635B12-indolinone derivatives as modulators of protein kinase activitySUGEN INC·Filed 1999·Granted Nov 13, 2001·87 cites·29 claims
- 3493US6225346B1Tyrphostin like compoundsSUGEN INC·Filed 1999·Granted May 1, 2001·61 cites·9 claims
- 3592US7230098B2Aminoheteroaryl compounds as protein kinase inhibitorsSUGEN INC·Filed 2004·Granted Jun 12, 2007·73 cites·15 claims
- 3692US6103728AQuinazolinesSUGEN INC·Filed 1997·Granted Aug 15, 2000·58 cites·11 claims
- 3792US5602171AMethods of inhibiting phosphatase activity and treatment of disorders associated therewith using naphthopyrones and derivatives thereofSUGEN INC·Filed 1995·Granted Feb 11, 1997·54 cites·12 claims
- 3891US7186716B23-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitorsSUGEN INC·Filed 2003·Granted Mar 6, 2007·64 cites·12 claims
- 3991US6143765APharmaceutical compositions and methods for modulating signal transductionSUGEN INC·Filed 1998·Granted Nov 7, 2000·44 cites·22 claims
- 4090US7186832B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Mar 6, 2007·32 cites·4 claims
- 4190US6696482B2Formulations for hydrophobic pharmaceutical agentsSUGEN INC·Filed 2001·Granted Feb 24, 2004·34 cites·29 claims
- 4290US6696448B23-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitorsSUGEN INC·Filed 2002·Granted Feb 24, 2004·65 cites·4 claims
- 4390US6689806B1Indolinone compounds as kinase inhibitorsSUGEN INC·Filed 2000·Granted Feb 10, 2004·29 cites·19 claims
- 4490US6395734B1Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 1999·Granted May 28, 2002·79 cites·23 claims
- 4590US5942385AMethod for molecular diagnosis of tumor angiogenesis and metastasisSUGEN INC·Filed 1996·Granted Aug 24, 1999·145 cites·19 claims
- 4689US6911446B2Methods of modulating serine/threonine protein kinase function with quinazoline-based compoundsSUGEN INC·Filed 2001·Granted Jun 28, 2005·37 cites·17 claims
- 4789US6207401B1Diagnosis and treatment of AUR-1 and/or AUR-2 related disordersSUGEN INC·Filed 1999·Granted Mar 27, 2001·81 cites·6 claims
- 4889US6147106AIndolinone combinatorial libraries and related products and methods for the treatment of diseaseSUGEN INC·Filed 1997·Granted Nov 14, 2000·37 cites·15 claims
- 4989US5760066ACompounds and methods for inhibiting hyper-proliferative cell growthSUGEN INC·Filed 1996·Granted Jun 2, 1998·30 cites·28 claims
- 5088US6710067B2Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivativesSUGEN INC·Filed 2001·Granted Mar 23, 2004·20 cites·9 claims
Showing the top 50 of 216 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SUGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →